1. Transformation of myocarditis and inflammatory cardiomyopathy to idiopathic dilated cardiomyopathy: facts and fiction

   • Hans R. Figulla

   Review 01 November 2003 Pages: 61 - 64

   

2. Viral heart disease: molecular diagnosis, clinical prognosis, and treatment strategies

   • Matthias Pauschinger
   • Kumaran Chandrasekharan
   • Heinz-Peter Schultheiss

   Review 14 January 2004 Pages: 65 - 69

   

3. Coxsackieviral replication and pathogenicity: lessons from gene modified animal models

   • Rainer Wessely

   Review 25 October 2003 Pages: 71 - 74

4. Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy

   • Ulrich Lotze
   • Renate Egerer
   • Hans R. Figulla

   Original Investigation 20 December 2003 Pages: 75 - 82

   

5. Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency

   • Ralph Feuer
   • Ignacio Mena
   • J. Lindsay Whitton

   Original Investigation 19 August 2003 Pages: 83 - 90

   

6. Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice

   • Roland Zell
   • René Markgraf
   • Brigitte Glück

   Original Investigation 26 September 2003 Pages: 91 - 100

   

7. Molecular pathology of inflammatory cardiomyopathy

   • Karin Klingel
   • Martina Sauter
   • Reinhard Kandolf

   Original Investigation 14 August 2003 Pages: 101 - 107

   

8. Detection of enterovirus capsid protein VP1 in myocardium from cases of myocarditis or dilated cardiomyopathy by immunohistochemistry: further evidence of enterovirus persistence in myocytes

   • Hongyi Zhang
   • Yanwen Li
   • Leonard C. Archard

   Original Investigation 22 November 2003 Pages: 109 - 114

   

9. The humoral immune response in viral heart disease: characterization and pathophysiological significance of antibodies

   • Peter L. Schwimmbeck
   • Boris Bigalke
   • Heinz-Peter Schultheiss

   Original Investigation 04 February 2004 Pages: 115 - 119

   

10. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside

    • Cornel Badorff
    • Kirk U. Knowlton

    Original Investigation 12 August 2003 Pages: 121 - 126

    

11. Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism

    • Hans-Christoph Selinka
    • Antje Wolde
    • Karin Klingel

    Original Investigation 14 August 2003 Pages: 127 - 131

    

12. Characterization of coxsackievirus B3-caused apoptosis under in vitro conditions

    • Ulrike Martin
    • Matthias Nestler
    • Andreas Henke

    Original Investigation 12 September 2003 Pages: 133 - 139

    

13. Coxsackievirus B3-induced myocarditis: differences in the immune response of C57BL/6 and Balb/c mice

    • Carola Leipner
    • Katja Grün
    • Axel Stelzner

    Original Investigation 31 October 2003 Pages: 141 - 147

    

14. Interferons in enteroviral heart disease: modulation of cytokine expression and antiviral activity

    • Albert Heim
    • Sabine Weiss

    Original Investigation 12 September 2003 Pages: 149 - 154